维持肝衰竭内环境稳态的临床实践

doi:10.3969/j.issn.1672-5069.2014.02.004

Abstract

Nie Qinghe，Zhu Ting.. Maintenance of internal environment homeostasis in patients with liver failure[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(2): 125-128.

[1] Zeidel ML. Water homeostasis:evolutionary medicine.Trans Am Clin Climatol Assoc，2012，123（2）:93-105.
[2] 张绪清，聂青和. 重型肝炎水、电解质紊乱和酸碱失衡的诊断与治疗. 实用肝脏病杂志，2004，7（2）:72-74.
[3] Yu C，Sharma N，Saab S，et al. Hyponatremia:clinical associations，prognosis，and treatment in cirrhosis. Exp Clin Transplant，2013，11（1）:3-11.
[4] 聂青和. 肝衰竭综合治疗进展．实用肝脏病杂志，2013，16（1）:17-19.
[5] Deetjen P，Lichtwarck-Aschoff M. Practical diagnostics of acid-base disorders. PartII:Complex metabolic disturbances. Anaesthesist，2012，61（12）:1067-1076.
[6] 聂青和. 肝硬化慢性肝衰竭临床治疗实践. 中国实用内科杂志，2013，33（9）:698-701.
[7] 中华医学会感染病学分会肝衰竭与人工肝学组.肝衰竭诊治指南（2012年版）. 实用肝脏病杂志，2013，16（3）：210-216.
[8] Crdenas A，Ginès P，Marotta P，et al. Tolvaptan，an oral vasopressin antagonist，in the treatment of hyponatremia in cirrhosis.J Hepatol，2012，56（3）:571-578.
[9] Montejo González JC，Mesejoa A，Bonet Saris A，et al. Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus SEMICYUC-SENPE: Liver failure and liver transplantation. Nutr Hosp，2011，26（2）:27-31.
[10] 聂青和. 肝衰竭实验室检测的临床价值及新指标评价.临床肝胆病杂志，2013，29（9）:666-669.
[11] Thanapirom K，Treeprasertsuk S，Komolmit P，et al. Comparison of long-term outcome of patients with Wilson's disease presenting with acute liver failure versus acute-on-chronic liver failure. J Med Assoc Thai，2013，96（2）:150-156.
[12] Plank LD，Gane EJ，Peng S，et al.Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis:a randomized 12-month trial.Hepatology，2008，48（2）:557-566.
[13] Meng QH，Hou W，Yu HW，et al. Resting energy expenditure and substrate metabolism in patients with acute-on-chronic hepatitis B liver failure.J Clin Gastroenterol，2011，45（5）:456-461.
[14] Jurado García J，Costán Rodero G，Calanas-Continente A，et al. Importance of nutritional support in patients with hepatic encephalopathy. Nutr Hosp，2012，27（2）:372-381.
[15] Dou J，Xu W，Ye B，et al.Serum vitamin B12 levels as indicators of disease severity and mortality of patients with acute-on-chronic liver failure.Clin Chim Acta，2012，413（23-24）:1809-1812.
[16] Valentini L，Glaser S， Schuetz T， et al. Serum bile acids and leptin interact with glucose metabolism in patients with liver cirrhosis. Clin Nutr，2013，32（1）:122-129.
[17] 李梦东，聂青和.肝衰竭的研究现状与展望. 实用肝脏病杂志，2013，16（1）:9-11.
[18] 聂青和.重型肝炎综合治疗进展的临床教学实践及体会. 实用肝脏病杂志，2006，9（2）:104-106.

Maintenance of internal environment homeostasis in patients with liver failure

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhu Yucheng, Yan Jiawei, Sun Jingkun, et al. Serum diamine oxidase level in patients with hepatitis B-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2019, 22(5): 672-675.
[2]	Song Haiyan, Chen Xi, Zhang Junfei, et al. Application of vorionazole in the treatment of patients with liver failure complicated by pulmonary fungal infection [J]. Journal of Practical Hepatology, 2019, 22(5): 676-679.
[3]	Zhang Xuan, Tang Xiaoyun, Tang Chunyin, et al. Effect of Chinese herbal medicine on intestinal microflora in mice with D-galactosamine/LPS-induced acute liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 478-481.
[4]	Wang Yuan, Dang Panyu, Wang Wei. Application of plasma exchange and continuous plasma dialysis filtration in the treatment of patients with acute-on-chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 541-544.
[5]	Peng Silu, Liu Bing, Sun Hong, et al. Prognosis of patients with hepatitis B-induced acute-on-chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 545-548.
[6]	Zhong Song, Liu Yuyuan, Liu Shuren. G2D expression of peripheral blood natural killer cells in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 341-344.
[7]	Pan Jinjin, Dong Jing, Song Haiyan. Clinical efficacy of glucosteroid on blocking disease progress in patients with nucleos（t）ide analogue withdrawal hepatitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 357-360.
[8]	Guideline for diagnosis, treatment of liver failure. [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 164-171.
[9]	Song Fangjiao, Zhu Bing, Lyu Sa, Tian Hua, Wang Haibo, Xin Shaojie, You Shaoli. Clinical analysis of drug-induced liver failure：a report of 314 cases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 216-219.
[10]	Zhang Xiuling, Duan Zhiwen, Yang Ruidong, Zhang Xiaomin, Yang Li, Yang Haiqiu, Li Wu. Plasma exchange combined with double plasma molecular adsorption system in treatment of patients with liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 289-290.
[11]	Fan Jiangao.. Highlights of Journal of Practical Hepatology in 2018 [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 1-3.
[12]	Chen Haiou, Liu Shi.. Implication of serum IL-10 and GP73 levels in patients with HBV-related acute-on-chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 73-76.
[13]	Ma Deyuan, Ma Yuanfeng, Zhang Dianlong, et al.. Prognostic efficacy of serum keratin 18 in patients with hepatitis B virus-related acute on chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 77-80.
[14]	Yan Huanjie, Zhang Shuqin, Zhao Wenjing.. Therapeutic efficacy of autologous bone marrow stem cell transplantation for treatment of patients with hepatitis B-induced acute-on-chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 81-84.
[15]	Zhang Jing, Yin Fang, Luo Guanhong, et al.. Effect of plasma exchange and sequential double plasma molecular adsorbent therapy on short survival in patients with hepatitis B virus-induced acute on chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 85-88.